In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects

Autor: Jinho Kim, Mackenzie Welch, Robert J. Ferrante, Emmanuel Brouillet, Noelle Dufour, Philippe Hantraye, Nicole Déglon, Richard Gilmore, Gilles Bonvento, Mathilde Faideau, Kerry Cormier, Martine Guillermier, Gwennaelle Auregan
Jazyk: angličtina
Rok vydání: 2010
Předmět:
Time Factors
Huntingtin
Amino Acid Transport System X-AG
Fluorescent Antibody Technique
Mice
0302 clinical medicine
Genetics (clinical)
Neurons
Serotonin Plasma Membrane Transport Proteins
0303 health sciences
Glial fibrillary acidic protein
Glutamate receptor
Articles
General Medicine
Middle Aged
3. Good health
Astrogliosis
Cell biology
Huntington Disease
Phenotype
medicine.anatomical_structure
Biochemistry
Neuroglia
Astrocyte
Dopamine and cAMP-Regulated Phosphoprotein 32
Central nervous system
Down-Regulation
Glutamic Acid
Biology
Receptors
N-Methyl-D-Aspartate

03 medical and health sciences
Huntington's disease
Glial Fibrillary Acidic Protein
Genetics
medicine
Animals
Humans
Molecular Biology
Aged
030304 developmental biology
Lentivirus
Biological Transport
medicine.disease
Neostriatum
nervous system
Astrocytes
biology.protein
Mutant Proteins
Peptides
Trinucleotide Repeat Expansion
030217 neurology & neurosurgery
Zdroj: Human Molecular Genetics; Vol 19
Human Molecular Genetics
ISSN: 1460-2083
DOI: 10.1093/hmg/ddq212
Popis: Huntington's disease (HD) is a neurodegenerative disorder previously thought to be of primary neuronal origin, despite ubiquitous expression of mutant huntingtin (mHtt). We tested the hypothesis that mHtt expressed in astrocytes may contribute to the pathogenesis of HD. To better understand the contribution of astrocytes in HD in vivo, we developed a novel mouse model using lentiviral vectors that results in selective expression of mHtt into striatal astrocytes. Astrocytes expressing mHtt developed a progressive phenotype of reactive astrocytes that was characterized by a marked decreased expression of both glutamate transporters, GLAST and GLT-1, and of glutamate uptake. These effects were associated with neuronal dysfunction, as observed by a reduction in DARPP-32 and NR2B expression. Parallel studies in brain samples from HD subjects revealed early glial fibrillary acidic protein expression in striatal astrocytes from Grade 0 HD cases. Astrogliosis was associated with morphological changes that increased with severity of disease, from Grades 0 through 4 and was more prominent in the putamen. Combined immunofluorescence showed co-localization of mHtt in astrocytes in all striatal HD specimens, inclusive of Grade 0 HD. Consistent with the findings from experimental mice, there was a significant grade-dependent decrease in striatal GLT-1 expression from HD subjects. These findings suggest that the presence of mHtt in astrocytes alters glial glutamate transport capacity early in the disease process and may contribute to HD pathogenesis.
Databáze: OpenAIRE